SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
latest_posts
- 1
The Drone Video of the Year is stunning – you've not seen Namibia like this - 22025 Was Another Exceptionally Hot Year
- 3Turkey key underlying issue as Israel, Greece, Cyprus hold summit
- 4China resumes flights to North Korea after a six-year pause
- 5Finding Europe's Head Traveler Objections: An Excursion Through Famous Attractions
- Baidu robotaxi outage in Wuhan caused by 'system failure', police say
- India’s delayed climate plan sets modest emission target
- These 45 exoplanets may be the best places to search for alien life
- How is 'A Knight of the Seven Kingdoms' connected to 'Game of Thrones'?
- 7 Espresso Machines for Home Baristas
- Dark matter obeys gravity after all — could that rule out a 5th fundamental force in the universe?
- Bayer reports positive results for blood thinner after 2023 setback
- Everyone knows F1 is for the girls. I wandered into the Las Vegas desert to find out why.
- How to Build a Yard That Helps Monarchs During Spring Migration
